Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

May 14, 2021

Dr. Reddy’s signs license deal for anti-BCMA CAR-T PRG1801 in India

Dr. Reddy's Laboratories has signed an agreement with Shenzhen Pregene Biopharma to acquire an exclusive license in India for PRG1801, Pregene's single domain antibody-based anti-BCMA chimeric antigen receptor T (CAR-T) cell therapy injection.

Dr. Reddy’s signs license deal for anti-BCMA CAR-T PRG1801 in India